The glucagon-like peptide (GLP) teduglutide is effective for long-term treatment of patients with short-bowel syndrome intestinal failure, according to the July issue of Clinical Gastroenterology and Hepatology. Short-bowel syndrome is a relatively rare condition that results from massive small bowel resection or bypass. Patients used to die from nutrient malabsorption
Read moreIn patients with chronic Hepatitis C virus (HCV) infection, a sustained viral response to treatment regimens 12 weeks after therapy (SVR12) is a good indicator that the response will be maintained until week 24 (SVR 24), based on an analysis of pooled clinical trial data published in the June issue of
Read moreIndividuals with invasive pancreatic cancer or high-grade dysplasia can be identified based on a specific DNA mutation in pancreatic juice samples from the duodena, according to the June issue of Clinical Gastroenterology and Hepatology. Tests for mutant TP53 might be developed to improve the diagnosis of and screening for pancreatic cancer and its precursors.
Read moreDrug-induced liver injury (DILI) could be more common than previously believed, according to a population-based study published in the June issue of Gastroenterology. Amoxicillin-clavulanate seems to be the most common cause, and azathioprine appears to be the most hepatotoxic. Many medications, such chlorpromazine, azathioprine, and sulfasalazine, can cause liver injury,
Read moreNot only does celiac disease cause abdominal pain, diarrhea, and bloating—untreated disease leads to progressive bone loss and derangements, increasing the risk for early osteoporosis and fractures of the hip and vertebrae. The June issue of Clinical Gastroenterology and Hepatology reports that current screening strategies to identify people with celiac
Read moreMany patients with primary sclerosing cholangitis (PSC) also have inflammatory bowel disease (IBD), which becomes more severe after liver transplantation, researchers report in the May issue of Clinical Gastroenterology and Hepatology. These patients might require special immunosuppressive regimens. PSC is a chronic, cholestatic liver disease that eventually leads to cirrhosis
Read moreA study of zebrafish has helped identify a susceptibility gene for biliary atresia, as reported in the May issue of Gastroenterology. Biliary atresia is a progressive fibro-inflammatory disorder of infants that involves the extrahepatic and intrahepatic biliary tree and causes obliteration of the ducts, leading to cholestasis, fibrosis, and cirrhosis.
Read moreAmong patients who continuously take nonsteroidal anti-inflammatory drugs (NSAIDs), a third of co-prescriptions for drugs to prevent gastrointestinal (GI) damage are not renewed within the next 2 years. This discontinuation increases patients’ risk of stomach pain, inflammation, or ulcers, according to the May issue of Clinical Gastroenterology and Hepatology. Patients
Read more
Dr. Kristine Novak has worked as an editor at biomedical research journals and as a science writer for over 15 years, covering advances in gastroenterology, hepatology, cancer, immunology, biotechnology, molecular genetics, and clinical trials. She has a PhD in cell biology and an interest in all areas of medical research.
|
|
|
|
© 2021 iMagPress. All Rights Reserved.
A Special Issue: the Exocrine Pancreas and its Disorders
Everything you ever wanted to know about the pancreas, its development and function, and the pathogenesis and treatment of its disorders are now covered in a special issue of Gastroenterology. Pancreatology is a rapidly developing field—recent findings from molecular and genetic studies are being developed into new treatment strategies. To update
Read more